トリプトファン代謝の再プログラミングはTh1/Th2免疫バランスを調節し、マスト細胞の活性化を阻害する
Dongsheng Huang1, Dongxuan Huang2, Lianhui Su2
1Department of Respiratory and Critical Care Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, Guangdong, China. 13417310023@163.com.
Amino acids
|March 1, 2026
まとめ
高トリプトファンレベルはTh1免疫応答を促進し、マスト細胞の活性化を抑制するため、トリプトファン代謝は免疫バランスの是正を通じて喘息の潜在的な治療標的となることを示唆する。
科学分野:
- 免疫学
- 代謝経路
- アレルギー性炎症
背景:
- 喘息は、慢性的な気道炎症とTh1/Th2免疫応答の偏りを含む。
- トリプトファン代謝がTh1/Th2分化とマスト細胞活性に及ぼす役割は十分に理解されていない。
研究 の 目的:
- 異なるトリプトファン濃度がTh1/Th2細胞の分極にどのように影響するかを調査する。
- トリプトファンがマスト細胞の活性化に及ぼす影響を決定する。
- トリプトファン代謝を喘息の潜在的な治療標的として探求する。
主な方法:
- CD4+ T細胞およびLAD2マスト細胞を異なるトリプトファン濃度で培養した。
- 細胞表現型および代謝経路を分析するためにフローサイトメトリー、ウェスタンブロッティング、RT-qPCRを使用した。
- マスト細胞活性化マーカーを評価するために免疫蛍光染色およびELISAを使用した。
主要な成果:
- トリプトファンの利用可能性の増加は、IL-2、IFN-γ、Notch1/Jagged1、T-bet、mTORの上昇、およびIL-4とGATA3の低下によって示されるように、Th1分化を増強した。
- トリプトファンはマスト細胞の活性化を抑制し、トリプターゼ発現とヒスタミン放出を減少させた。
- IDO1/TDOの阻害は、ヒスタミン放出に対するトリプトファンの効果を部分的に逆転させ、トリプトファン異化作用が関与していることを示唆した。
結論:
- トリプトファンの利用可能性は免疫代謝を再プログラミングし、Th1分化を促進し、マスト細胞の活性化を抑制する。
- この二重作用は、トリプトファン代謝がTh1/Th2バランスを是正し、アレルギー性炎症を軽減できることを示唆している。
- トリプトファン代謝は、新規喘息治療のための有望な免疫代謝標的となる。
関連する概念動画
Repressible Operon: trp Operon
2.1K
The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
2.1K
T Cell Types and Functions
2.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
Amino Acid Biosynthetic Pathways
1.5K
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.5K
Inflammatory Response
17.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.6K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K


